Bernard Birkett - 02 Aug 2022 Form 4 Insider Report for WEST PHARMACEUTICAL SERVICES INC (WST)

Signature
Ryan Metz as Agent for Bernard Birkett
Issuer symbol
WST
Transactions as of
02 Aug 2022
Net transactions value
-$4,836,074
Form type
4
Filing time
03 Aug 2022, 15:24:25 UTC
Previous filing
23 Jun 2022
Next filing
23 Feb 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction WST Common Stock Sale $3,186,695 -9,359 -63% $340.50 5,610 02 Aug 2022 Direct F1
transaction WST Common Stock Sale $584,083 -1,708 -30% $341.97 3,902 02 Aug 2022 Direct F2
transaction WST Common Stock Sale $687,574 -2,007 -51% $342.59 1,895 02 Aug 2022 Direct F3
transaction WST Common Stock Sale $377,723 -1,100 -58% $343.38 795 02 Aug 2022 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $340.1950 to $340.8100, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
F2 The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $341.2700 to $342.2600, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
F3 The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $342.28 to $342.93, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
F4 The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $343.31 to $343.67, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.